Stroke attributable to acute basilar occlusion

被引：6

作者：

Bergui M. ^{[1
]}

Cerrato P. ^{[1
]}

Bradac G.B. ^{[1
]}

机构：

[1] Division of Neuroradiology, Neuroscience Department, University of Turin, 10126 Torino

来源：

Current Treatment Options in Neurology | 2007年 / 9卷 / 2期

关键词：

Basilar Artery; Intravenous Thrombolysis; Superior Cerebellar Artery; Prodromal Phase; Basilar Artery Occlusion;

D O I：

10.1007/s11940-007-0038-x

中图分类号：

学科分类号：

摘要：

Acute basilar artery occlusion carries a high risk of disabling stroke or death. Fast recanalization of the vessel is the mainstay of the therapy. Recanalization may be achieved by intravenous or intra-arterial administration of thrombolytics. These procedures are currently used as life-saving interventions, despite the low level of evidence supporting their efficacy, because of the bad prognosis of the disease. Intravenous thrombolysis may be started earlier, but it is less often used, mainly for historic reasons; intra-arterial measures are possibly more effective in achieving recanalization but require extra time before they can be started and demand a considerable amount of resources. The basilar artery does not recanalize in approximately one third of patients; this result has not been modified over the past two decades by these treatments and probably will not change. Combined mechanical and intra-arterial thrombolysis may be more efficient in achieving basilar artery recanalization, but the impact of this combined intervention on the final outcome has not been evaluated. Because time is critical, as in every stroke, implementation of a specific treatment protocol for this condition, including one of the aforementioned treatments, and eventual transfer to a secondary-care unit will save time and improve prognosis. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：126 / 135

页数：9

共 54 条

[21]

Lindsberg P.J., Soinne L., Roine R.O., Tatlisumak T., Options for recanalization therapy in basilar artery occlusion, Stroke, 36, pp. 203-204, (2005)

[22]

Brandt T., von Kummer R., Mueller-Kuppers M., Hacke W., Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome, Stroke, 27, pp. 875-881, (1996)

[23]

Cross III D.T., Moran C.J., Akins P.T., Et al., Collateral circulation and outcome after basilar artery thrombolysis, Am J Neuroradiol, 19, pp. 1557-1563, (1998)

[24]

Voetsch B., DeWitt L.D., Pessin M.S., Caplan L.R., Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry, Arch Neurol, 61, pp. 496-504, (2004)

[25]

Hacke W., Kaste M., Fieschi C., Et al., Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), Lancet, 352, pp. 1245-1251, (1998)

[26]

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N Engl J Med, 333, pp. 1581-1587, (1995)

[27]

Schonewille W.J., Algra A., Serena J., Et al., Outcome in patients with basilar artery occlusion treated conventionally, J Neurol Neurosurg Psychiatry, 76, pp. 1238-1241, (2005)

[28]

Moscow N.P., Newton T.H., Angiographic implications in diagnosis and prognosis of basilar artery occlusion, Am J Roentgenol Radium Ther Nucl Med, 119, pp. 597-604, (1973)

[29]

Bruckmann H., Ferbert A., del Zoppo G.J., Et al., Acute vertebral-basilar thrombosis. Angiologic-clinical comparison and therapeutic implications, Acta Radiol Suppl, 369, pp. 38-42, (1986)

[30]

Ostrem J.L., Saver J.L., Alger J.R., Et al., Acute basilar artery occlusion: Diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies, Stroke, 35, pp. 30-34, (2004)

← 1 2 3 4 5 6 →